Episodes
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Myelofibrosis
July 1st, 2024 | Season 1 | 1 hr 6 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the optimal management of myelofibrosis with Dr Aaron T Gerds, moderated by Dr Neil Love. Produced by Research To Practice.
-
Clinical Update on the Current Management of Advanced Urothelial Bladder Cancer
June 17th, 2024 | Season 1 | 1 hr 23 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion of the current management of advanced urothelial bladder cancer with Dr Petros Grivas, moderated by Dr Neil Love. Produced by Research To Practice.
-
Striving for Consensus: Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer
June 12th, 2024 | Season 1 | 2 hrs 35 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on ovarian suppression for HR-positive breast cancer with Drs Gradishar, Kaklamani, Mayer and Wander moderated by Dr Neil Love. Produced by Research To Practice.
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer
June 11th, 2024 | Season 1 | 1 hr 48 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on treatments for NSCLC harboring targetable oncogenic alterations with Dr Justin F Gainor and Dr Karen Reckamp, moderated by Dr Neil Love. Produced by Research To Practice.
-
Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Urothelial Bladder Cancer
June 7th, 2024 | Season 1 | 1 hr 2 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on treatment for urothelial bladder cancer, including data presented at the 2024 AUA annual meeting, with Drs Matthew Galsky and Ashish Kamat, moderated by Dr Neil Love. Produced by Research To Practice.
-
Key Presentations on Lymphoma from Recent Major Conferences
May 28th, 2024 | Season 1 | 1 hr 16 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on follicular lymphoma, mantle cell lymphoma, diffuse large B-cell lymphoma and Hodgkin lymphoma with Dr Andrew D Zelenetz, moderated by Dr Neil Love. Produced by Research To Practice.
-
Bispecific Antibodies in the Management of Multiple Myeloma
May 24th, 2024 | Season 1 | 42 mins 8 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion of the role of bispecific antibodies in multiple myeloma with Dr Joshua Richter, moderated by Dr Neil Love. Produced by Research To Practice.
-
Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
May 24th, 2024 | Season 1 | 33 mins 54 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia with Dr Elias Jabbour, moderated by Dr Neil Love. Produced by Research To Practice.
-
Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer
May 20th, 2024 | Season 1 | 1 hr 16 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion discussion on evolving treatments for patients with localized HER2-expressing breast cancer with Dr Adam M Brufsky, moderated by Dr Neil Love. Produced by Research To Practice.
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia
May 13th, 2024 | Season 1 | 1 hr 2 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent developments in the diagnosis and treatment of acute myeloid leukemia with Drs Naval Daver and Courtney DiNardo, moderated by Dr Neil Love. Produced by Research To Practice.
-
Virtual Case Library: Metastatic Triple-Negative Breast Cancer
May 8th, 2024 | Season 1 | 2 hrs 13 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion of clinical decision-making for patients with mTNBC, with Drs Nanda, Tolaney, Foldi, Huppert and Shaikh moderated by Dr Neil Love. Produced by Research To Practice.
-
Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition
May 6th, 2024 | Season 1 | 1 hr 7 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on HER2-targeted therapies for patients with genitourinary cancers with Dr Matthew D Galsky, moderated by Dr Neil Love. Produced by Research To Practice.
-
Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer
May 3rd, 2024 | Season 1 | 59 mins 39 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the optimal management of gastroesophageal cancer with Prof Eric Van Cutsem, moderated by Dr Neil Love. Produced by Research To Practice.
-
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series
May 1st, 2024 | Season 1 | 1 hr 47 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the optimal management of myelofibrosis with Dr Ruben A Mesa, moderated by Dr Neil Love. Produced by Research To Practice.
-
Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria
April 26th, 2024 | Season 1 | 1 hr 37 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on paroxysmal nocturnal hemoglobinuria, with Dr Carlos de Castro, Prof Alexander Röth and Dr Ilene Weitz, moderated by Dr Neil Love. Produced by Research To Practice.
-
Special Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers Symposium
April 24th, 2024 | Season 1 | 59 mins 51 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring an overview of recent clinical data presented at the 2024 Genitourinary Cancers Symposium with Dr Emmanuel Antonarakis, moderated by Dr Neil Love. Produced by Research To Practice.